Better Health Worldwide is our name and our goal.Through access to our network, we partner with your team to develop and communicate research that ultimately will bring Better Health Worldwide. We've been developing new data assets.

I serve as the Research Abstracts and Posters Chairperson for the National Association of Specialty Pharmacy (NASP). In this capacity, I have worked to formalize the abstract submission and publications processes for research presented at the NASP annual meeting. NASP is a 501(c)(6) trade association representing all stakeholders in the specialty pharmacy industry. Our members include the nation's leading specialty pharmacies, pharmaceutical and biotechnology manufacturers, GPOs, distributors and more. Comprising some 90 corporate members and 2,000 individuals members, NASP is the unified voice of specialty pharmacy in the United States. NASP is dedicated to education, certification, national policy, patient advocacy, and extensive hands on clinical engagement of all stakeholders in the specialty pharmacy industry.

October 2016-Present Senior Vice PresidentJuly 2005-October 2016 Vice PresidentFormerly known as the National Managed Care Roundtable (NMCRT), the National Payor Roundtable provides an opportunity for pharmaceutical and medical organizations to interact with a number of different managed care plans in an efficient manner.Programs are similar to advisory board meeting and customized to client needs and are held periodically throughout the year.www.TPG-NPRT.com

The Pharmacy Group provides unique customer focused solutions within the healthcare market. Our channels include Managed Care, Pharmaceutical Companies, and Medical Device Manufacturers. In addition to our domestic work, we also provide healthcare Missions to the World with recent programs in New Zealand and India and a 2009 program to Santiago, Chile.

Edjudicate provides intelligent pharmaceutical solutions targeted at Educating physicians, pharmacists, and patients before and after claims are edjudicated.

At the end of 2018, we transitioned remaining business and data assets from The JeSTARx Group to Better Health Worldwide. We continue to focus on:*Identifying the best data available for a given challenge*Securing the data*Analyzing the data and *Partnering with companies to communicate the data through traditional and innovative channels.

Responsible for all formulary therapeutic interchange programs, formulary administrations, and development/integration of an expert system to code new NDCs and formularies through validated rules.

Was 1st health economics person at Sandoz (Now Novartis). Developed the economic programs to support Sandimmune Neoral in all solid organ transplants, Lamisil Oral, and various other portfolio programs. Developed the format for the corporate Economic Research and Development Plans.

Responsible for various internal strategic support projects. Developed incentive systems for sales forces, modeled compensation plans, new product development plans and other analytical projects.